Purchase Order 75N93023P01329
Award Date 9/18/23
Potential Completion Date 12/31/23
Potential Value $18K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Hamilton, MT 59840, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $18,180 firm fixed price purchase order to Creative Biolabs Inc. Creative Biolabs Division for lipopolysaccharide structure (LPS) analysis services. The work will be performed in East Yaphank, New York over a period of four months concluding in late December 2023. The National Institute of Allergy and Infectious Diseases conducts and supports research on...
- This is a $19,980.00 firm fixed price purchase order awarded by the Department of Health and Human Services' National Institutes of Health, National Cancer Institute to Creative Biolabs Inc. for laboratory testing services. The contract has a period of performance from May 15, 2024 to July 10, 2024 and does not have a set-aside designation. Creative Biolabs Inc. is a for-profit organization that specializes in providing custom biotechnology and pharmaceutical services to support federal...
- This is a firm fixed-price purchase order contract awarded by the National Cancer Institute, a component of the National Institutes of Health (NIH), to Creative Biolabs Inc., a for-profit biotechnology and pharmaceutical services company. The $9,980.00 contract is for lab testing services and does not have a set-aside designation. Creative Biolabs has a history of securing federal contracts from various civilian agencies, including the NIH and its specialized institutes, to provide advanced...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, has awarded a $210,338.00 firm fixed-price purchase order to Creative Biolabs Inc. for mouse antibody production services across Phases I through IV. The contract, which runs through September 22, 2025, does not have a set-aside designation. Creative Biolabs, a specialized biotechnology and pharmaceutical services provider, will deliver custom solutions in...
- CD Biosciences Inc., doing business as Creative Biomart, Creative Biolabs, CD Genomics, and Profacgen Division, has been awarded a $15,000 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide creative diagnostics glycoproteins and nucleoproteins. The contract has a period of performance from September 22, 2023 through December 29, 2023, with all work to be conducted by the prime contractor in East Yaphank, New...
- The Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order contract to Creative Biogene Inc., a self-certified small disadvantaged business, for the delivery of custom gene knockout cell lines. The potential value of the contract is $15,000.00, and the period of performance ends on August 16, 2020. Creative Biogene has a history of providing specialized biotechnology services,...
- Advanced Bioscience Laboratories, Inc., doing business as Advanced Bioscience Laboratories Inc., has been awarded a cost-plus-fixed-fee delivery order contract valued at approximately $1.78 million by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. Under this contract, Advanced Bioscience Laboratories will provide cGMP QS21 and produce cGMP ALF55 drug substance in support of the NIH's preclinical development efforts. Work will be performed in Potomac,...
- The prime contractor, Advanced Bioscience Laboratories, Inc., has been awarded a cost plus fixed fee contract valued at $1.8 million by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). Under this contract, Advanced Bioscience Laboratories, Inc. will provide preclinical development support services including project management, quality assurance/quality control,...
- This is a $23,990 firm fixed-price purchase order awarded by the National Institute on Aging (NIA), a civilian agency, to Creative Biogene Inc., a self-certified small disadvantaged business. The contract is for laboratory and testing services to study protein expression in plasma samples. No set-aside was used. The contract has an ultimate completion date of September 29, 2025. Creative Biogene Inc. is a biotechnology services company that provides advanced analytical techniques, such as...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $716,374 delivery order contract to Lovelace Biomedical Research Institute. Under the terms of the firm fixed price contract, Lovelace Biomedical Research Institute will conduct a Good Laboratory Practice repeat dose toxicology study for BPL-24910 in support of the Comprehensive and Rapid Response for NIAID Research Programs major program code. Performance...
Creative Biolabs Inc. has been awarded a $18,180 purchase order contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide LPS analysis services. The contract has a period of performance from September 18, 2023 through December 31, 2023 and utilizes a firm fixed price payment structure. Work will be conducted by Creative Biolabs' division in Hamilton, Montana to support the NIH/NIAID's research efforts. No major subcontractors or set aside designations were indicated. This award advances the NIH/NIAID's mission to conduct and support research on infectious and immune-mediated diseases.
Generated 12/20/23, 4:10 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.2k | 9/18/23 |